NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 146 filers reported holding NEKTAR THERAPEUTICS in Q3 2014. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $1,558,000 | +60.3% | 90,704 | +2.2% | 0.20% | -24.4% |
Q3 2015 | $972,000 | -19.4% | 88,717 | -19.1% | 0.27% | -38.6% |
Q1 2015 | $1,206,000 | +581.4% | 109,612 | +859.8% | 0.43% | +365.6% |
Q4 2014 | $177,000 | -23.7% | 11,420 | -36.8% | 0.09% | +43.1% |
Q2 2014 | $232,000 | +48.7% | 18,062 | +31.7% | 0.06% | +124.1% |
Q4 2013 | $156,000 | -81.6% | 13,710 | -83.1% | 0.03% | -84.7% |
Q3 2013 | $846,000 | – | 81,000 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Strong Tower Advisory Services | 404,972 | $6,913,000 | 4.02% |
GREAT POINT PARTNERS LLC | 504,691 | $9,064,000 | 2.11% |
Camber Capital Management LP | 3,750,000 | $67,350,000 | 2.07% |
ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,901,000 | 1.50% |
Rhenman & Partners Asset Management AB | 950,000 | $17,062,000 | 1.20% |
MAVERICK CAPITAL LTD | 5,838,426 | $104,858,000 | 1.06% |
Birchview Capital, LP | 72,000 | $1,293,000 | 0.88% |
Bellevue Group AG | 4,594,656 | $82,519,000 | 0.84% |
CM Management, LLC | 50,000 | $898,000 | 0.67% |
Duquesne Family Office | 1,000,000 | $17,960,000 | 0.58% |